Dolutegravir plus rilpivirine: benefits beyond viral suppression by Jesús Troya, MD, PhD, Carlos Dueñas, MD, Idoia Irazola, MD, Ignacio de los Santos, MD, PhD, Sara de la Fuente, MD, PhD, Desiré Gil, MD, PhD, Cristina Hernández, MD, María José Galindo, MD, PhD, Julia Gómez, MD, Elisabeth Delgado, MD, Estela Moreno-García, MD, Guillermo Posada, MD, PhD, Teresa Aldámiz, MD, PhD, Jose Antonio Iribarren, MD, José Manuel Guerra, MD, PhD, Miguel Ángel Morán, MD, Carlos Galera, MD, PhD, Javier Fuente, MD, Ana Peláez, MD, PhD, Miguel Cervero, MD, PhD, María Garcinuño, MD, Marta Montero, MD, Francisco Ceballos, PhD, Luis Buzón, MD, PhD, on behalf of the DORIPEX Study Group∗∗

Get full text